SWELL:
Journal of Clinical Oncology: “Elevated biomarkers for inflammation are linked to decreased survival in breast cancer patients.”
International Journal of Environmental Research and Public Health: “Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Interventional Research.”
Current pharmaceutical design: “Inflammation drives tumor progression and metastasis.”
Cynthia Lynch, MD, Medical Oncologist, Breast Cancer Program Clinical Advisor, Cancer Treatment Centers of America, Phoenix, AZ.
Naoto Tada Ueno, MD, PhD, Department Head, Translational Breast Cancer Research, Breast Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX.
Oncotarget: “Inflammatory reactions and inflammation-related diseases of the organs.”
Tina J. Hieken, MD, surgical oncologist, Mayo Clinic; Professor of Surgery, Mayo Clinic College of Medicine, Rochester, MN.
Scientific Reports: “The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Diseases.”
Molecules: “The microbiome and its implications for cancer immunotherapy.”
University of Washington Center for Ecogenetics and Environmental Health: “Fast Facts on the Human Microbiome.”
Johns Hopkins Medicine, “Fecal Transplantation (Bacteriotherapy).”
Press release, Australian Science Media Center Inc.
National Center for Biotechnology Information: “StatPearls: Chronic Inflammation.”
Mayo Clinic: “How Much Should the Average Adult Exercise Each Day?”
American Cancer Society: “Alcohol Use and Cancer.”
PLOS ONE: “The Link Between Cigarette Smoking and Inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study.”
Scripps Health: “Six Keys To Reducing Inflammation.”
Comments are closed.